Eloxx Pharmaceuticals, Inc.
ELOX· Nasdaq
Eloxx Pharmaceuticals, Inc.
- Last sale
- Oct 1, 2026 · +3.18%
- Market cap
- $62.16M
- 4.04M shares
- Filings
- 1,013
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $6,359,000 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2014 | 2014-06-30 | $182,229 | reported | |
| FY 2013 | 2013-06-30 | $7,819 | reported | |
| FY 2012 | 2012-06-30 | $200,000 | reported | |
| FY 2010 | 2010-06-30 | $140,000 | reported |
Eloxx Pharmaceuticals, Inc. · CIK 1035354 · Engraved from SEC EDGAR
